• The global Oral Medicines for Diabetes market was valued at US$ 62970 million in 2023 and is projected to reach US$ 124450 million by 2030, at a CAGR of 10.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• Oral medications for diabetes are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
• Oral Medicines for Diabetes Market aims to provide a comprehensive presentation of the global market for Oral Medicines for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Medicines for Diabetes. Oral Medicines for Diabetes Market contains market size and forecasts of Oral Medicines for Diabetes in global, including the following market information:
Email: help@24marketreports.com Call: +1(646)-781-7170
Biguanides
Sulfonylureas
Meglitinides
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
SGLT2 Inhibitors
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Other
